Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
about
Current stage in inflammatory bowel disease: What is next?IL-17 family: cytokines, receptors and signalingReview article: vitamin D and inflammatory bowel disease--established concepts and future directionsImmunopathology of inflammatory bowel diseaseOverview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseasesValidation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug EffectsTh1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85AThe changes of Th17 cells and the related cytokines in the progression of human colorectal cancers.Bifidobacterium breve attenuates murine dextran sodium sulfate-induced colitis and increases regulatory T cell responsesImmunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cellsStat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis.The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease.A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.Th17-related cytokines: new players in the control of chronic intestinal inflammationIL-23/IL-17 axis in IBD.Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice.Inflammation and gastrointestinal Candida colonizationAdipose-tissue and intestinal inflammation - visceral obesity and creeping fatReduced surface expression of epithelial E-cadherin evoked by interferon-gamma is Fyn kinase-dependentGallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c miceInterleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis.Distinct profiles of effector cytokines mark the different phases of Crohn's diseaseDifferential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics.Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implicationsAryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update.An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity.IL-17A signaling in colonic epithelial cells inhibits pro-inflammatory cytokine production by enhancing the activity of ERK and PI3K.Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.The th17/treg immune balance in ulcerative colitis patients with two different chinese syndromes: dampness-heat in large intestine and spleen and kidney yang deficiency syndromeProstaglandin E2 and IL-23 plus IL-1β differentially regulate the Th1/Th17 immune response of human CD161(+) CD4(+) memory T cells.Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritisEndogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease.Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced ColitisMoxibustion and Acupuncture Ameliorate Crohn's Disease by Regulating the Balance between Th17 and Treg Cells in the Intestinal Mucosa.Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease.In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells.Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice.Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease
P2860
Q26777429-7B0265E0-773A-4BAF-A028-9BC3BA1AD722Q26860251-0EDF29E8-D9B3-4AD7-AC28-49101903328FQ27015639-83240078-B708-4DA1-93C6-4366874D23E1Q27027636-36B10401-59AF-4404-8F62-C2D4C64DF57DQ28069372-71206EE6-B18B-4432-8288-B74F7C666F1AQ28552013-7C7B6350-2850-4DA1-8524-977B9E25755BQ28740954-B12EA955-645D-49C8-ADB9-CF2600FD7C5DQ31096343-A412AB60-8D08-49EC-8261-F745D0CAB53BQ33559718-B783605D-2294-4DBB-8C58-01F446A49C8EQ33632901-EDDC00D0-7550-4206-97C8-F07E784DD82CQ34002679-C89FB845-B878-441A-9208-7AF53D31308FQ34027844-CCEF02FD-A00C-455B-ADCA-FAC99253E4A0Q34058468-4DDED026-2CFF-4380-9773-3CE5C9178077Q34074137-947FEABA-5C9F-4864-B8A0-1652E4DBEC03Q34103438-ABF2FF4F-CB32-4080-A1CB-D5A52BCCD2E0Q34124662-ED0A0AEB-CADA-478A-AB7D-AB95DCAA74CAQ34204874-E5E2D03A-633A-4CF1-9B12-173FB6C68702Q34239249-126DC0F6-AA32-44BC-852C-88841BB733B3Q34310254-0D2A9181-DC31-440D-9817-B12415D00803Q34488647-DCC16D7F-0B3B-4BA8-B1FC-976E2840DB69Q34499227-0BFB68BD-1595-491C-8296-65377A47B911Q34563301-4AA518CF-88CF-4C00-82B0-4CF13F7CC5E0Q34626740-A64B855E-7690-4162-9678-0000E93A0D36Q34712244-8B7108EB-CA52-4638-9EED-44FD306942D5Q34969719-B331E4BA-911E-44E7-BED7-56AC6CFDECA6Q35026302-632B4772-CEAB-4661-BA0B-BE9A5194DB34Q35087828-0B707703-9DC2-454E-AEBF-C1E57E21F75CQ35107947-51E312DE-04A0-4D41-BD4A-35D54618BA66Q35136750-9AC30DF7-281A-43C6-94A4-6F704834AAB2Q35177977-A07569D1-12AF-4D4D-B764-C75C5F5CF0CCQ35205751-2BBBEAB5-1F04-41E9-B44E-F4AFA1CA9AEAQ35669339-FC040D9E-085B-478C-A899-0300D2902A3CQ35690113-8FDDCB50-9773-4741-8E5C-E999FA9DD7E0Q35913586-91CDA0A4-942C-47EE-951D-FF8C065EEB10Q35963975-A900150C-3F7C-47F9-BA16-4971D471A80CQ35964497-5BF83DF8-77A5-4C90-BB60-EC085642F11AQ36052633-241BC4C4-86E8-460C-8EB1-91ED0A45A39DQ36063507-B2B4FFDA-ED3D-4488-BC95-0376BAC8A71FQ36130948-6C780519-13F9-4B9A-96B0-D8AE00A74ED8Q36237186-047EE79D-2C07-4B2D-9CE7-EE3ED36869F2
P2860
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Differential regulation of int ...... in inflammatory bowel disease.
@ast
Differential regulation of int ...... in inflammatory bowel disease.
@en
type
label
Differential regulation of int ...... in inflammatory bowel disease.
@ast
Differential regulation of int ...... in inflammatory bowel disease.
@en
prefLabel
Differential regulation of int ...... in inflammatory bowel disease.
@ast
Differential regulation of int ...... in inflammatory bowel disease.
@en
P2093
P356
P1433
P1476
Differential regulation of int ...... in inflammatory bowel disease.
@en
P2093
A Di Sabatino
C H Knowles
D S Rampton
G Monteleone
G R Corazza
L Rovedatti
P Biancheri
T T Macdonald
P304
P356
10.1136/GUT.2009.182170
P407
P577
2009-09-08T00:00:00Z